Methadone dose blood-level study and monitoring
Treatments studied
Part of Mental health clinical trials.
This study measures how methadone moves through your body by using planned blood samples and computer modeling. It may help doctors better predict methadone levels to support safer dosing for people already taking methadone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult taking methadone at the same dose for at least 7 days
- You are being treated in the addictology department at La Colombière (for withdrawal in hospital) or seen there as an outpatient
- Your care team can do 24 hours of monitoring, and you are willing to stay under monitoring
- Your veins are strong enough for the blood samples needed for the study
- You can understand the study and share written informed consent
- You are in France and covered by the French social security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that remotely checks your methadone dose. It may help people taking methadone for at least one week get more convenient care.
This study is checking the levels of methadone and its breakdown products in your blood. It helps make sure the medication is working safely for conditions like opioid use disorder or chronic pain.
This trial is for people with chronic pain who take daily methadone. It aims to measure how much methadone is in your body to help doctors find the right dose.
This study compares taking methadone as one dose versus split into two doses to see which approach works better for people who have pain. It’s meant for adults already on a steady methadone program and who can follow study visits and procedures.
This trial tests a system where nurses can adjust your methadone dose without a doctor's order. It's for people starting methadone treatment for opioid use disorder and willing to be followed at a CSAPA center for 3 months.
This study tests a new way to start methadone treatment (called 'MethaLoad') for people with opioid use disorder who have used fentanyl. If you qualify, you will receive methadone to help manage withdrawal and reduce cravings, and the doctors will closely monitor your safety and response.
Hear when a new Toxicomania trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.